Prothena reported 22.11 in PE Price to Earnings for its fiscal quarter ending in March of 2022.





Pe Change Date
Acadia Pharmaceuticals 9.52 1.81 Sep/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Akebia Therapeutics 1.63K 1.6K Dec/2025
ALKERMES 262.4 126.59 Sep/2026
Alnylam Pharmaceuticals 13.17 62.47 Sep/2026
Amgen 18.6 0.53 Sep/2026
Biogen 29.15 5.92 Sep/2026
BioMarin Pharmaceutical 53.62 32.55 Sep/2026
Exelixis 18.43 0.41 Sep/2026
Incyte 54.54 40.08 Sep/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 83.17 61.07 Sep/2026
Prothena 22.11 11.37 Mar/2022
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Vertex Pharmaceuticals 29.35 1.3 Sep/2026